Epidemiology of heart failure with preserved ejection fraction.
Nat Rev Cardiol. 14: 591-602Obokata M. Reddy Y.N.V. Borlaug B.A.Diastolic dysfunction and heart failure with preserved ejection fraction: understanding mechanisms by using noninvasive methods.
JACC Cardiovasc Imaging. 13: 245-257Chirinos J.A. Orlenko A. Zhao L. et al.Multiple plasma biomarkers for risk stratification in patients with heart failure and preserved ejection fraction.
J Am Coll Cardiol. 75: 1281-1295Pfeffer M.A. Shah A.M. Borlaug B.A.Heart failure with preserved ejection fraction in perspective.
Circ Res. 124: 1598-1617Smiseth O.A. Morris D.A. Cardim N. et al.Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging.
Eur Heart J Cardiovasc Imaging. 23: e34-e61Yancy C.W. Jessup M. Bozkurt B. et al.2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.
Circulation. 128 ()Pieske B. Tschöpe C. de Boer R.A. et al.How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
Eur Heart J. 40: 3297-3317Reddy Y.N.V. Carter R.E. Obokata M. et al.A Simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction.
Circulation. 138: 861-870Sepehrvand N. Alemayehu W. Dyck G.J.B. et al.External validation of the H(2)F-PEF model in diagnosing patients with heart failure and preserved ejection fraction.
Circulation. 139: 2377-2379Lang R.M. Badano L.P. Mor-Avi V. et al.Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.
J Am Soc Echocardiogr. 28: 1-39.e14Zile M.R. Gottdiener J.S. Hetzel S.J. et al.Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction.
Circulation. 124: 2491-2501Lam C.S. Roger V.L. Rodeheffer R.J. et al.Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota.
Circulation. 115: 1982-1990Morris D.A. Ma X.X. Belyavskiy E. et al.Left ventricular longitudinal systolic function analysed by 2D speckle-tracking echocardiography in heart failure with preserved ejection fraction: a meta-analysis.
Open Heart. 4: e000630Wang J. Khoury D.S. Yue Y. et al.Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure.
Eur Heart J. 29: 1283-1289Lumens J. Delhaas T. Arts T. et al.Impaired subendocardial contractile myofiber function in asymptomatic aged humans, as detected using MRI.
Am J Physiol Heart Circ Physiol. 291: H1573-H1579Martinez D.A. Guhl D.J. Stanley W.C. et al.Extracellular matrix maturation in the left ventricle of normal and diabetic swine.
Diabetes Res Clin Pract. 59: 1-9Nagueh S.F. Smiseth O.A. Appleton C.P. et al.Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging.
J Am Soc Echocardiogr. 29: 277-314Left atrial size and function: role in prognosis.
J Am Coll Cardiol. 63: 493-505Inoue K. Khan F.H. Remme E.W. et al.Determinants of left atrial reservoir and pump strain and use of atrial strain for evaluation of left ventricular filling pressure.
Eur Heart J Cardiovasc Imaging. 23: 61-70Morris D.A. Belyavskiy E. Aravind-Kumar R. et al.Potential usefulness and clinical relevance of adding left atrial strain to left atrial volume index in the detection of left ventricular diastolic dysfunction.
JACC Cardiovasc Imaging. 11: 1405-1415Lam C.S. Roger V.L. Rodeheffer R.J. et al.Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study.
J Am Coll Cardiol. 53: 1119-1126Andersen O.S. Smiseth O.A. Dokainish H. et al.Estimating left ventricular filling pressure by echocardiography.
J Am Coll Cardiol. 69: 1937-1948Lancellotti P. Galderisi M. Edvardsen T. et al.Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study.
Eur Heart J Cardiovasc Imaging. 18: 961-968Williams B. Mancia G. Spiering W. et al.2018 ESC/ESH Guidelines for the management of arterial hypertension.
Eur Heart J. 39: 3021-3104Olsen F.J. Møgelvang R. Modin D. et al.Association between isometric and allometric height-indexed left atrial size and atrial fibrillation.
J Am Soc Echocardiogr. 35: 141-150.e4Nagueh S.F. Chang S.M. Nabi F. et al.Cardiac imaging in patients with heart failure and preserved ejection fraction.
Circ Cardiovasc Imaging. 10: e006547Obokata M. Kane G.C. Reddy Y.N. et al.Role of diastolic stress testing in the evaluation for heart failure with preserved ejection fraction: a simultaneous invasive-echocardiographic study.
Circulation. 135: 825-838Hwang S.J. Melenovsky V. Borlaug B.A.Implications of coronary artery disease in heart failure with preserved ejection fraction.
J Am Coll Cardiol. 63: 2817-2827Rush C.J. Berry C. Oldroyd K.G. et al.Prevalence of coronary artery disease and coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
JAMA Cardiol. 6: 1130-1143Obokata M. Reddy Y.N.V. Melenovsky V. et al.Myocardial injury and cardiac reserve in patients with heart failure and preserved ejection fraction.
J Am Coll Cardiol. 72: 29-40Bravo P.E. Di Carli M.F. Dorbala S.Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies.
Heart Fail Rev. 22: 455-464Jaarsma C. Leiner T. Bekkers S.C. et al.Diagnostic performance of noninvasive myocardial perfusion imaging using single-photon emission computed tomography, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease: a meta-analysis.
J Am Coll Cardiol. 59: 1719-1728Taqueti V.R. Solomon S.D. Shah A.M. et al.Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.
Eur Heart J. 39: 840-849Chirinos J.A. Segers P. Hughes T. et al.Large-artery stiffness in Health and disease: JACC state-of-the-art review.
J Am Coll Cardiol. 74: 1237-1263Maron B.J. Desai M.Y. Nishimura R.A. et al.Diagnosis and evaluation of hypertrophic cardiomyopathy: JACC state-of-the-art review.
J Am Coll Cardiol. 79: 372-389Rowin E.J. Maron B.J. Maron M.S.The hypertrophic cardiomyopathy phenotype viewed through the prism of multimodality imaging: clinical and etiologic implications.
JACC Cardiovasc Imaging. 13: 2002-2016Chan R.H. Maron B.J. Olivotto I. et al.Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
Circulation. 130: 484-495Multimodality imaging for the diagnosis of infiltrative cardiomyopathies.
Heart. 108: 98-104Seward J.B. Casaclang-Verzosa G.Infiltrative cardiovascular diseases: cardiomyopathies that look alike.
J Am Coll Cardiol. 55: 1769-1779Nochioka K. Quarta C.C. Claggett B. et al.Left atrial structure and function in cardiac amyloidosis.
Eur Heart J Cardiovasc Imaging. 18: 1128-1137Dorbala S. Ando Y. Bokhari S. et al.ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.
J Nucl Cardiol. 26: 2065-2123Phelan D. Collier P. Thavendiranathan P. et al.Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.
Heart. 98: 1442-1448Fontana M. Chung R. Hawkins P.N. et al.Cardiovascular magnetic resonance for amyloidosis.
Heart Fail Rev. 20: 133-144Baggiano A. Boldrini M. Martinez-Naharro A. et al.Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis.
JACC Cardiovasc Imaging. 13: 69-80Fontana M. Banypersad S.M. Treibel T.A. et al.Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac mr imaging study.
Radiology. 277: 388-397Kittleson M.M. Maurer M.S. Ambardekar A.V. et al.Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the american heart association.
Circulation. 142: e7-e22Perry R. Shah R. Saiedi M. et al.The role of cardiac imaging in the diagnosis and management of anderson-fabry disease.
JACC Cardiovasc Imaging. 12: 1230-1242Linhart A. Kampmann C. Zamorano J.L. et al.Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey.
Eur Heart J. 28: 1228-1235Kozor R. Grieve S.M. Tchan M.C. et al.Cardiac involvement in genotype-positive Fabry disease patients assessed by cardiovascular MR.
Heart. 102: 298-302Thompson R.B. Chow K. Khan A. et al.T₁ mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex.
Circ Cardiovasc Imaging. 6: 637-645Augusto J.B. Nordin S. Vijapurapu R. et al.Myocardial edema, myocyte injury, and disease severity in fabry disease.
Circ Cardiovasc Imaging. 13: e010171Nappi C. Altiero M. Imbriaco M. et al.First experience of simultaneous PET/MRI for the early detection of cardiac involvement in patients with Anderson-Fabry disease.
Eur J Nucl Med Mol Imaging. 42: 1025-1031Waldek S. Patel M.R. Banikazemi M. et al.Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry.
Genet Med. 11: 790-796Fabry disease and its cardiac involvement.
J Gen Fam Med. 18: 225-229Nakao S. Takenaka T. Maeda M. et al.An atypical variant of Fabry's disease in men with left ventricular hypertrophy.
N Engl J Med. 333: 288-293Trivieri M.G. Spagnolo P. Birnie D. et al.Challenges in cardiac and pulmonary sarcoidosis: JACC state-of-the-art review.
J Am Coll Cardiol. 76: 1878-1901Slart R. Glaudemans A. Lancellotti P. et al.A joint procedural position statement on imaging in cardiac sarcoidosis: from the cardiovascular and inflammation & infection committees of the European association of nuclear medicine, the European association of cardiovascular imaging, and the American society of nuclear cardiology.
J Nucl Cardiol. 25: 298-319Anderson L.J. Holden S. Davis B. et al.Cardiovascular T2-star (T2∗) magnetic resonance for the early diagnosis of myocardial iron overload.
Eur Heart J. 22: 2171-2179Kirk P. Roughton M. Porter J.B. et al.Cardiac T2∗ magnetic resonance for prediction of cardiac complications in thalassemia major.
Circulation. 120: 1961-1968Torlasco C. Cassinerio E. Roghi A. et al.Role of T1 mapping as a complementary tool to T2∗ for non-invasive cardiac iron overload assessment.
PLoS One. 13: e0192890Sweeney M. Corden B. Cook S.A.Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?.
EMBO Mol Med. 12: e10865Mascherbauer J. Marzluf B.A. Tufaro C. et al.Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction.
Circ Cardiovasc Imaging. 6: 1056-1065Duca F. Kammerlander A.A. Zotter-Tufaro C. et al.Interstitial fibrosis, functional status, and outcomes in heart failure with preserved ejection fraction: insights from a prospective cardiac magnetic resonance imaging study.
Circ Cardiovasc Imaging. 9: e005277Su M.Y. Lin L.Y. Tseng Y.H. et al.CMR-verified diffuse myocardial fibrosis is associated with diastolic dysfunction in HFpEF.
JACC Cardiovasc Imaging. 7: 991-997Assadi H. Jones R. Swift A.J. et al.Cardiac MRI for the prognostication of heart failure with preserved ejection fraction: a systematic review and meta-analysis.
Magn Reson Imaging. 76: 116-122Nacif M.S. Liu Y. Yao J. et al.3D left ventricular extracellular volume fraction by low-radiation dose cardiac CT: assessment of interstitial myocardial fibrosis.
J Cardiovasc Comput Tomogr. 7: 51-57Hahn V.S. Yanek L.R. Vaishnav J. et al.Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis.
JACC Heart Fail. 8: 712-724Lewis G.A. Dodd S. Clayton D. et al.Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial.
Nat Med. 27: 1477-1482Chirinos J.A. Kips J.G. Jacobs Jr., D.R. et al.Arterial wave reflections and incident cardiovascular events and heart failure: MESA (Multiethnic Study of Atherosclerosis).
J Am Coll Cardiol. 60: 2170-2177Karagodin I. Aba-Omer O. Sparapani R. et al.Aortic stiffening precedes onset of heart failure with preserved ejection fraction in patients with asymptomatic diastolic dysfunction.
BMC Cardiovasc Disord. 17: 62Chi C. Liu Y. Xu Y. et al.Association between arterial stiffness and heart failure with preserved ejection fraction.
Front Cardiovasc Med. 8: 707162Noninvasive evaluation of left ventricular afterload: part 1: pressure and flow measurements and basic principles of wave conduction and reflection.
Hypertension. 56: 555-562Segers P. Rietzschel E.R. Chirinos J.A.How to measure arterial stiffness in humans.
Arterioscler Thromb Vasc Biol. 40: 1034-1043Echocardiographic assessment of large artery stiffness.
J Am Soc Echocardiogr. 29: 1117-1121Matsushita K. Ding N. Kim E.D. et al.Cardio-ankle vascular index and cardiovascular disease: systematic review and meta-analysis of prospective and cross-sectional studies.
J Clin Hypertens (Greenwich). 21: 16-24Budoff M.J. Alpert B. Chirinos J.A. et al.Clinical applications measuring arterial stiffness: an expert consensus for the application of cardio-ankle vascular index (CAVI).
Am J Hypertens. 35: 441-453Spronck B. Obeid M.J. Paravathaneni M. et al.Predictive ability of pressure-corrected arterial stiffness indices: comparison of pulse wave velocity, cardio-ankle vascular index (CAVI), and CAVI0.
Am J Hypertens. 35: 272-280Arterial wall stiffness: basic principles and methods of measurement in vivo.
Elsevier/Academic Press, London, UKPulsatile arterial haemodynamics in heart failure.
Eur Heart J. 39: 3847-3854Ikonomidis I. Aboyans V. Blacher J. et al.The role of ventricular-arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases, European Association of Cardiovascular Imaging, and Heart Failure Association.
Eur J Heart Fail. 21: 402-424Chirinos J.A. Sweitzer N.Ventricular-arterial coupling in chronic heart failure.
Card Fail Rev. 3: 12-18Ventricular-arterial coupling: invasive and non-invasive assessment.
Artery Res. 7Essential principles of pulsatile pressure-flow relations in the arterial tree.
in: Chirinos J.A. Textbook of arterial stiffness and pulsatile hemodynamics in Health and disease. Academic Press/Elsevier, London, UK: 49-65Mitchell GF. Assessment of ventricular arterial interactions via arterial pressure-flow relations in humans. London. UK: Academic Press/Elsevier.
Selvaraj S. Kim J. Ansari B.A. et al.Body composition, natriuretic peptides, and adverse outcomes in heart failure with preserved and reduced ejection fraction.
JACC Cardiovasc Imaging. 14: 203-215The HFpEF obesity phenotype: the elephant in the room.
J Am Coll Cardiol. 68: 200-203Obokata M. Reddy Y.N.V. Pislaru S.V. et al.Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction.
Circulation. 136: 6-19Koepp K.E. Obokata M. Reddy Y.N.V. et al.Hemodynamic and functional impact of epicardial adipose tissue in heart failure with preserved ejection fraction.
JACC Heart Fail. 8: 657-666Cruz-Jentoft A.J. Bahat G. Bauer J. et al.Sarcopenia: revised European consensus on definition and diagnosis.
Age Ageing. 48: 16-31Haykowsky M.J. Kouba E.J. Brubaker P.H. et al.Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction.
Am J Cardiol. 113: 1211-1216Kitzman D.W. Nicklas B. Kraus W.E. et al.Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction.
Am J Physiol Heart Circ Physiol. 306: H1364-H1370Kogan F. Hariharan H. Reddy R.Chemical exchange saturation transfer (CEST) imaging: description of technique and potential clinical applications.
Curr Radiol Rep. 1: 102-114Kumar A.A. Kelly D.P. Chirinos J.A.Mitochondrial dysfunction in heart failure with preserved ejection fraction.
Circulation. 139: 1435-1450Zamani P. Proto E.A. Wilson N. et al.Multimodality assessment of heart failure with preserved ejection fraction skeletal muscle reveals differences in the machinery of energy fuel metabolism.
ESC Heart Fail. 8: 2698-2712Kumar A. Ansari B.A. Kim J. et al.Axial muscle size as a strong predictor of death in subjects with and without heart failure.
J Am Heart Assoc. 8: e010554Salah H.M. Pandey A. Soloveva A. et al.Relationship of nonalcoholic fatty liver disease and heart failure with preserved ejection fraction.
JACC Basic Transl Sci. 6: 918-932Hepatic venous compliance and role of liver as a blood reservoir.
Am J Physiol. 231: 292-295Fudim M. Sobotka P.A. Dunlap M.E.Extracardiac abnormalities of preload reserve: mechanisms underlying exercise limitation in heart failure with preserved ejection fraction, autonomic dysfunction, and liver disease.
Circ Heart Fail. 14: e007308Liver ultrasound elastography: more than staging the disease.
World J Hepatol. 7: 1595-1600Barr R.G. Wilson S.R. Rubens D. et al.Update to the society of radiologists in ultrasound liver elastography consensus statement.
Radiology. 296: 263-274Guglielmo F.F. Venkatesh S.K. Mitchell D.G.Liver MR elastography technique and image interpretation: pearls and pitfalls.
Radiographics. 39: 1983-2002van de Wouw J. Broekhuizen M. Sorop O. et al.Chronic kidney disease as a risk factor for heart failure with preserved ejection fraction: a focus on microcirculatory factors and therapeutic targets.
Front Physiol. 10: 1108Iida N. Seo Y. Sai S. et al.Clinical implications of intrarenal hemodynamic evaluation by Doppler ultrasonography in heart failure.
JACC Heart Fail. 4: 674-682de la Espriella-Juan R. Núñez E. Miñana G. et al.Intrarenal venous flow in cardiorenal syndrome: a shining light into the darkness.
ESC Heart Fail. 5: 1173-1175Puzzovivo A. Monitillo F. Guida P. et al.Renal venous pattern: a new parameter for predicting prognosis in heart failure outpatients.
J Cardiovasc Dev Dis. 5Ennezat P.V. Maréchaux S. Six-Carpentier M. et al.Renal resistance index and its prognostic significance in patients with heart failure with preserved ejection fraction.
Nephrol Dial Transpl. 26: 3908-3913Wu J. Shi Z. Zhang Y. et al.Native T1 mapping in assessing kidney fibrosis for patients with chronic glomerulonephritis.
Front Med (Lausanne). 8: 772326
留言 (0)